ContractProtea Biosciences Group, Inc. • August 9th, 2013 • Pharmaceutical preparations • Delaware
Company FiledAugust 9th, 2013 Industry JurisdictionTHIS WARRANT AND THE SECURITIES UNDERLYING THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, ASSIGNED, PLEDGED, OR HYPOTHECATED IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION THEREFROM UNDER SUCH SECURITIES ACT, ANY APPLICABLE STATE SECURITIES LAWS AND THE RULES AND REGULATIONS THEREUNDER.
Securities Purchase AgreementSecurities Purchase Agreement • August 9th, 2013 • Protea Biosciences Group, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 9th, 2013 Company Industry JurisdictionThis Securities Purchase Agreement (the “Agreement”) is made as of [ ], 2013 (the “Effective Date”) by and among Protea Biosciences Group, Inc., a Delaware corporation (the “Company”), and the undersigned purchaser (the “Purchaser”).
CONVERSION AGREEMENTConversion Agreement • August 9th, 2013 • Protea Biosciences Group, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 9th, 2013 Company Industry JurisdictionTHIS CONVERSION AGREEMENT (the "Agreement"), dated as of _________, 2013, by and among, Protea Biosciences Group, Inc., a Delaware corporation (the "Company") and the undersigned holder (a "Holder" and together with the other as set forth on Schedule A hereto of the Company’s convertible promissory notes, the "Holders").